ARTIVA BIOTHERAPEUTICS
2.2400
17-أبريل-25 16:45:00
15 متأخرة بدقائق
الأسهم
-0.0600
-2.61%
نطاق اليوم
2.1500 - 2.2700
ISIN
N/A
المصدر
NASDAQ
-
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
08 أبريل 2025 16:05:00 بحسب Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
31 مارس 2025 16:05:00 بحسب Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
24 مارس 2025 16:05:00 بحسب Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
20 فبراير 2025 16:05:00 بحسب Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
29 يناير 2025 16:05:00 بحسب Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
12 نوفمبر 2024 16:05:01 بحسب Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
11 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
22 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
10 سبتمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
29 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
18 يوليو 2024 19:08:52 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >